Editas Medicine

Editas Medicine

Employees:
90
Market Cap:
$852.28 million
Revenue:
$6.03 million
Net Income:
$-104.08 million

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia

Editas Medicine

Employees:
90
Market Cap:
$852.28 million
Revenue:
$6.03 million
Net Income:
$-104.08 million

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia